Can family history be used as a tool for public health and preventive medicine?

Genetics in Medicine

Volumn 4, Issue 4, 2002, Pages 304-310

  Yoon, Paula W ^a   Scheuner, Maren T ^b   Peterson Oehlke, Kris L ^a   Gwinn, Maria ^a   Faucett, Andrew ^c   Khoury, Muin J ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CHRONIC DISEASE; CLINICAL ASSESSMENT TOOL; DIABETES MELLITUS; ENVIRONMENTAL FACTOR; FAMILY HISTORY; GENE MUTATION; GENETIC DISORDER; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; NOTE; PREVENTIVE MEDICINE; PUBLIC HEALTH SERVICE; RISK FACTOR; STROKE; ANAMNESIS; ARTICLE; ETHICS; FAMILY HEALTH; METHODOLOGY; PREDICTION AND FORECASTING; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH; RISK ASSESSMENT;

FAMILY HEALTH; HUMANS; MEDICAL HISTORY TAKING; PREDICTIVE VALUE OF TESTS; PREVENTIVE HEALTH SERVICES; PUBLIC HEALTH; RISK ASSESSMENT;

EID: 0036653105     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/00125817-200207000-00009     Document Type: Note

References (51)

1. Yoon PW, Chen B, Faucett A, Clyne M, Gwinn M, Lubin IM, Burke W, Khoury MJ. The public health impact of genetic tests at the end of the 20th century. Genet Med 2001;3:405-410.
2. Rimoin DL, Connor JM, Pyeritz RE, editors. Principles and practices of medical genetics, 3rd ed. London: Churchill Livingstone, 1997:31.
3. Hedenfalk I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R, Meltzer P, Gusterson B, Esteller M, Kallioniemi OP, Wilfond B, Borg A, Trent J. Gene-expression profiles in hereditary breast cancer. N Engl J Med 2001;344:539-548.
4. Ishibe N, Kelsey KT. Genetic susceptibility to environmental and occupational cancers. Cancer Causes Control 1997;8:504-513.
5. Rockhill B, Kawachi I, Colditz GA. Individual risk prediction and population-wide disease prevention. Epidemiol Rev 2000;22:176-180.
6. Williams RR, Hunt SX, Heiss G, Province MA, Bensen JT, Higgins M, Chamberlain RM, Ware J, Hopkins PN. Usefulness of cardiovascular family history data for population-based preventive medicine and medical research (the Health Family Tree Study and the NHLBI Family Health Study). Am J Cardiol 2001;87:129-135.
7. Hunt SC, Williams RR, Barlow GK. A comparison of positive family history definitions for defining risk of future disease. J Chronic Dis 1986;39:809-821.
8. King RA, Rotter JI, Motulsky AG, editors. The genetic basis of common diseases. New York: Oxford University Press, 1992.
9. Scheuner MT, Wang SJ, Raffel LJ, Larabell SK, Rotter JI. Family history: a comprehensive genetic risk assessment method for the chronic conditions of adulthood. Am J Med Genet 1997;71:315-324.
10. Silberberg J, Fryer J, Wlodarczyk J, Robertson R, Dear K. Comparison of family history measures used to identify high risk of coronary heart disease. Genet Epidemiol 1999;16:344-355.
11. Hayflick SJ, Eiff MP, Carpenter L, Steinberger J. Primary care physician's utilization and perceptions of genetic services. Genet Med 1998;1:13-22.
12. Henderson LB, Scheuner MT. Suboptimal family history collection: an obstacle to genetic risk assessment and prevention. Am J Hum Genet 1998;63:A240.
13. Acheson LS, Wiesner GL, Zyzanski SJ, Goodwin MA, Stange KC. Family history-taking in community family practice: implications for genetic screening. Genet Med 2000;2:180-185.
14. Marteau TM, Lerman C. Genetic risk and behavior change. Br Med J 2001;322: 1056-1059.
15. Perera FP. Environment and cancer: who is susceptible? Science 1997;278:1068-1073.
16. Rose G. The strategy of preventive medicine. New York: Oxford University Press, 1992.
17. National Center for Health Statistics, Health-E Stat: http://wwv.cdc.gov/nchs/fastats/overwt.htm, 1999.
18. Eberhardt MS, Ingram DD, Makuc DM, et al. Urban and rural health chartbook: health, United States 2001. Hyattsville, MD: Centers for Disease Control and Prevention, National Center for Health Statistics, 2001.
19. Centers for Disease Control, and Prevention. Physical activity trends: United States, 1990-1998. MMWR 2001;50:166-169.
20. Department of Health and Human Services, Secretary's Advisory Committee on Genetic Testing. Request for public comment on a proposed classification methodology for determining level of review for genetic tests. Fed Reg 2000;65:76643-76645.
21. Kahn LB, Marshall JA, Baxter J, Shetterly SM, Hamman RF. Accuracy of reported family history of diabetes mellitus: results from San Luis Valley Diabetes Study. Diabetes Cure 1990;13:796.
22. Schenk M, Schwartz AG, O'Neal E, Kinnard M, Greenson JK, Fryzek JP, Ying GS, Garabrant DH. Familial risk of pancreatic cancer. J Natl Cancer Inst 2001;93:640-644.
23. Drews CD, Greenland S. The impact of differential recall on the results of case-control studies. Int J Epidemiol 1990;19:1107-1112.
24. Silberberg JS, Wlodarczyk J, Fryer J, Ray CD, Hensley MJ. Correction for biases in a population-based study of family history and coronary heart disease: the Newcastle Family History Study I. Am J Epidemiol 1998;147:1123-1132.
25. Last JM, editor. A dictionary of epidemiology, 3rd ed. New York: Oxford University Press; 1995:126.
26. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994;331:1669-1674.
27. Sandhu MS, Luben, Khaw KT. Prevalence and family history of colorectal cancer: implications for screening. J Med Screen 2001;8(2):69-72.
28. Bodmer W. Familial adenomatous polyposis (FAP) and its gene, APC. Cytogenet Cell Genet 1999;86:99-104.
29. Lynch HT, Lynch JF. Hereditary nonpolyposis colorectal cancer. Semin Surg Oncol 200;18:305-313.
30. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-1886.
31. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer: implication for risk prediction. Cancer 1994;73:643-651.
32. Leventhal H, Benyamini Y, Brownlee S, et al. Illness representations: theoretical foundations. In: Petrie KJ, Weinman JA, editors. Perceptions of health and illness. Amsterdam: Harwood, 1997.
33. Codori AM, Petersen GM, Miglioretti DL, Boyd P. Health beliefs and endoscopic screening for colorectal cancer: potential for cancer prevention. Prev Med 2001;33: 128-136.
34. Murabito JM, Evans JC, Larson MG, Kreger BE, Splansky GL, Freund KM, Moskowitz MA, Wilson PW. Family breast cancer history and mammography. Am J Epidemiol 2001;154:916-923.
35. Collins FS. Shattuck lecture: medical and societal consequences of the Human Genome Project. N Engl J Med 1999;341:28-37.
36. Milunsky A. Your genetic destiny. Cambridge, MA: Persues, 2001.
37. Levin ML. The occurrence of lung cancer in man. A eta Unio Int Contra Centrum 1953;19:531.
38. Ciruzzi M, Pramparo P, Rozlosnik J, Zylberstjn H, Delmonte H, Haquim M, Abecasis B, de La Cruz Ojeda J, Mele E, La Vecchia C, Schargrodsky H. Frequency of family history of acute myocardial infarction in patients with acute myocardial infarction. Argentine FRICAS (Factores de Riesgo Coronario en America del Sur) Investigators. Am J Cardiol 1997;80:122-127.
39. Silberberg JS, Wlodarczyk J, Fryer J, Robertson R, Hensley MJ. Risk associated with various definitions of family history of coronary heart disease: the Newcastle Family History Study II. Am J Epidemiol 1998;147:1133-1139.
40. Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 1997;71:800-809.
41. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001;358:1389-1399.
42. Cerhan JR, Parker AS, Putnam SD, Chiu BC, Lynch CF, Cohen MB, Torner JC, Cantor KP. Family history and prostate cancer risk in a population-based cohort of Iowa men. Cancer Epidemiol Biomarkers Prev 1999;8:53-60.
43. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate 1990;17:337-347.
44. Holman CD, Armstrong BK. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst 1984;72:257-266.
45. Cutler C, Foulkes WD, Brunet JS, Flanders TY, Shibata H, Narod SA. Cutaneous malignant melanoma in women is uncommonly associated with a family history of melanoma in first degree relatives: a case-control study. Melanoma Res 1996;6:435-440.
46. Klein BE, Klein R, Moss SE, Cruickshanks KJ. Parental history of diabetes in a population-based study. Diabetes Care 1996;19:827-830.
47. Bjornholt JV, Erikssen G, Liestol K, Jervell J, Thaulow E, Erikssen J. Type 2 diabetes and maternal family history: an impact beyond slow glucose removal rate and fasting hyperglycemia in low-risk individuals? Results from 22.5 years of follow-up of healthy nondiabetic men. Diabetes Care 2000;23:1255-1259.
48. Keen RW, Hart DJ, Arden NK, Doyle DV, Spector TD. Family history of appendicular fracture and risk of osteoporosis: a population-based study. Osteoporos Int 1999;10:161-166.
49. Fox KM, Cummings SR, Powell-Threets K, Stone K. Family history and risk of osteoporotic fracture: Study of Osteoporotic Fractures Research Group. Osteoporos Int 1998;8:557-562.
50. Tariq SM, Matthews SM, Hakim EA, Stevens M, Arshad SH, Hide DW. The prevalence of and the risk factors for atopy in early childhood: a whole population birth cohort study. J Allergy Clin Immunol 1998;101(5):587-593.
51. Genes for asthma? An analysis of the European Community Respiratory Health Survey. Am J Respir Crit Care Med 1997;156:1773-1780.